首页> 外文OA文献 >The Catenin p120ctn Interacts with Kaiso, a Novel BTB/POZ Domain Zinc Finger Transcription Factor
【2h】

The Catenin p120ctn Interacts with Kaiso, a Novel BTB/POZ Domain Zinc Finger Transcription Factor

机译:连环蛋白p120ctn与Kaiso相互作用,Kaiso是新型BTB / POZ域锌指转录因子

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

p120ctn is an Armadillo repeat domain protein with structural similarity to the cell adhesion cofactors β-catenin and plakoglobin. All three proteins interact directly with the cytoplasmic domain of the transmembrane cell adhesion molecule E-cadherin; β-catenin and plakoglobin bind a carboxy-terminal region in a mutually exclusive manner, while p120 binds the juxtamembrane region. Unlike β-catenin and plakoglobin, p120 does not interact with α-catenin, the tumor suppressor adenomatous polyposis coli (APC), or the transcription factor Lef-1, suggesting that it has unique binding partners and plays a distinct role in the cadherin-catenin complex. Using p120 as bait, we conducted a yeast two-hybrid screen and identified a novel transcription factor which we named Kaiso. Kaiso’s deduced amino acid sequence revealed an amino-terminal BTB/POZ protein-protein interaction domain and three carboxy-terminal zinc fingers of the C2H2 DNA-binding type. Kaiso thus belongs to a rapidly growing family of POZ-ZF transcription factors that include the Drosophila developmental regulators Tramtrak and Bric à brac, and the human oncoproteins BCL-6 and PLZF, which are causally linked to non-Hodgkins’ lymphoma and acute promyelocytic leukemia, respectively. Monoclonal antibodies to Kaiso were generated and used to immunolocalize the protein and confirm the specificity of the p120-Kaiso interaction in mammalian cells. Kaiso specifically coprecipitated with a variety of p120-specific monoclonal antibodies but not with antibodies to α- or β-catenin, E-cadherin, or APC. Like other POZ-ZF proteins, Kaiso localized to the nucleus and was associated with specific nuclear dots. Yeast two-hybrid interaction assays mapped the binding domains to Arm repeats 1 to 7 of p120 and the carboxy-terminal 200 amino acids of Kaiso. In addition, Kaiso homodimerized via its POZ domain but it did not heterodimerize with BCL-6, which heterodimerizes with PLZF. The involvement of POZ-ZF proteins in development and cancer makes Kaiso an interesting candidate for a downstream effector of cadherin and/or p120 signaling.
机译:p120ctn是一种犰狳重复结构域蛋白,与细胞粘附辅因子β-catenin和plakoglobin的结构相似。这三种蛋白质都直接与跨膜细胞粘附分子E-cadherin的胞质域相互作用。 β-catenin和Plagloglobin以互斥方式结合羧基末端区域,而p120结合近膜区域。与β-catenin和plakoglobin不同,p120不与α-catenin,抑癌性腺瘤性息肉病大肠杆菌(APC)或转录因子Lef-1相互作用,这表明它具有独特的结合伴侣,并且在钙黏着蛋白中起着独特的作用。连环蛋白复合物。使用p120作为诱饵,我们进行了酵母双杂交筛选,并鉴定了一种新的转录因子,我们将其命名为Kaiso。 Kaiso推导的氨基酸序列揭示了一个氨基末端BTB / POZ蛋白-蛋白质相互作用域和三个C2H2 DNA结合类型的羧基末端锌指。因此,Kaiso属于一个快速增长的POZ-ZF转录因子家族,包括果蝇发育调节剂Tramtrak和Bricàbrac,以及人类癌蛋白BCL-6和PLZF,它们与非霍奇金淋巴瘤和急性早幼粒细胞白血病有因果关系, 分别。产生了针对Kaiso的单克隆抗体,并将其用于免疫定位蛋白质并确认哺乳动物细胞中p120-Kaiso相互作用的特异性。 Kaiso与各种p120特异性单克隆抗体特异性共沉淀,但不与α-或β-catenin,E-cadherin或APC抗体共沉淀。像其他POZ-ZF蛋白一样,Kaiso定位于细胞核,并与特定的核点相关。酵母二杂交相互作用测定法将结合域映射到p120的Arm重复序列1至7和Kaiso的羧基末端200个氨基酸。此外,Kaiso通过其POZ结构域同源二聚体,但未与BCL-6异二聚体,后者与PLZF异二聚体。 POZ-ZF蛋白参与发育和癌症的发展使得Kaiso成为钙粘蛋白和/或p120信号传导下游效应子的有趣候选者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号